New gene therapy SNUG01 targets ALS in first human trial
NCT ID NCT07169175
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This early-stage study tests a new gene therapy called SNUG01 in 21 adults with ALS. The main goal is to check if it is safe and tolerable, and to see early signs of whether it might slow the disease. Participants receive the treatment via a spinal injection and are closely monitored for side effects and any changes in their condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350000, China
-
Massachusetts General Hospital
Boston, Massachusetts, 02467, United States
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100000, China
-
Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.